OTC Markets Group Inc. (OTCQX:OTCM) announced that clinical-stage biotechnology company Thiogenesis Therapeutics has qualified to trade on the OTCQX Best Market.
Thiogenesis Therapeutics upgraded from the Pink Market and its shares will commence trading today under the ticker symbol “TTIPF.”